Harry Silvers
Investor Relations Manager, United Therapeutics Corporation
Replay available
United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call
United Therapeutics Corporation (NASDAQ: UTHR) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Martine Rothblatt
Chairperson & Chief Executive Officer, United Therapeutics Corporation
Michael Bankiewicz
President & Chief Operating Officer, United Therapeutics Corporation
Ash Verma
Analyst, UBS
Dr. Lee Peterson
Executive Vice President of Product Development and Xenotransplantation, United Therapeutics Corporation
Conference Technical Support
Call Technician
Orlando Ruiz
Analyst, LeeRank Partners
Roger Song
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for United Therapeutics Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.155 Good morning, everyone, and welcome to the United Therapeutics Corporation fourth quarter 00:00:04.155 -- 00:00:08.040 2025 corporate update conference call. 00:00:08.040 -- 00:00:11.503 My name is Jamie, and I'll be your conference operator today. 00:00:11.503 -- 00:00:16.128 All participants on the call portion of this webcast will be in a listen-only mode until 00:00:16.128 -- 00:00:20.073 the question and answer portion of this earnings call. 00:00:20.073 -- 00:00:25.098 If you would like to ask a question during that time, please simply press star and 00:00:25.098 -- 00:00:28.786 then the number one on your telephone keypads. 00:00:28.786 -- 00:00:32.311 If you would like to withdraw your questions, you may simply press star and the number 00:00:32.311 -- 00:00:35.015 two on your telephone keypads. 00:00:35.015 -- 00:00:37.919 We do ask that you please limit yourselves to one question. 00:00:37.919 -- 00:00:40.783 Please also note today's event is being recorded. 00:00:40.783 -- 00:00:44.869 At this time, I'd like to turn the webcast over to Harry Silvers, Investor Relations 00:00:44.869 -- 00:00:48.051 Manager at United Therapeutics. 00:00:48.855 -- 00:00:53.000 Thank you, Jamie. Good morning. It is my pleasure to welcome you to the United Therapeutics 00:00:53.000 -- 00:00:57.727 Corporation fourth quarter 2025 corporate update webcast. 00:00:57.727 -- 00:01:02.093 Remarks today will include forward-looking statements representing our expectations or 00:01:02.093 -- 00:01:06.960 beliefs regarding future events. These statements involve risks and uncertainties that 00:01:06.960 -- 00:01:10.444 may cause actual results to differ materially. 00:01:10.444 -- 00:01:15.872 Our latest SEC filings, including forms 10-K and 10-Q, con...